Product Detail
rac Lasofoxifene-D₄
Lasofoxifene Stable Isotopes
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotopes
API Family
Lasofoxifene
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
rac Lasofoxifene-D₄ Product Information
rac Lasofoxifene-D₄ is listed under Stable Isotopes. It is associated with Lasofoxifene and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-103716.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
rac Lasofoxifene-D₄
CAS No.
1126626-61-6
CAT No.
CS-T-103716
Molecular Formula
C₂₈H₂₇D₄NO₂
Molecular Weight
417.58
Category
API Family
Storage Condition
Refer MSDS for complete information.
SMILES
OC1=CC=C2[C@@H](C3=CC=C(OC([2H])([2H])C([2H])([2H])N4CCCC4)C=C3)[C@@H](C5=CC=CC=C5)CCC2=C1
IUPAC Name
rel-(5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy-d4]phenyl]-2-naphthalenol; rac-(5R-cis)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy-d4]
Hazard Compound
Refer MSDS for complete information.
Description
Overview
rac Labelled Lasofoxifene (L176500). A next-generation selective estrogen receptor modulator for treating disorders associated with increased bone turnover and osteopenia.
Synonyms
rel-(5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy-d4]phenyl]-2-naphthalenol; rac-(5R-cis)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy-d4]
Application Notes
rac Labelled Lasofoxifene (L176500). A next-generation selective estrogen receptor modulator for treating disorders associated with increased bone turnover and osteopenia.
References
Baumann, R., et al.: Biochem. Pharmacol., 55, 841 (1998); Ammann, P., et al.: Osteoporos Int., 10, 369 (1999); Alexandersen, P., et al.: J. Clin. Endocrinol. Metab., 86, 755 (2001); Bourrin, S., et al.: Bone, 30, 195 (2002); Buzdar, A., et al.: J. Clin. Oncol., 21, 1007 (2003)
